Carbohydrate-Based Vaccines: An Overview
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Vaccination is one of the key developments in the fight against infectious diseases. It is based on the principle that immunization with pathogen-derived antigens provides protection from the respective infection by inducing an antigen-specific immune response. The discovery by Avery and Heidelberger in the 1920s that capsular polysaccharides (CPS) from Streptococcus pneumoniae are immunoreactive was the starting point of the development of carbohydrate-based vaccines. CPS-specific neutralizing antibodies were found to mediate protection against S. pneumoniae infection. Since the majority of bacterial pathogens carry a dense array of polysaccharides on their surface, the carbohydrate-based vaccine approach was applied to a variety of bacterial strains. The first CPS-based vaccines against S. pneumoniae were licensed in the 1940s. The increasing emergence of antibiotic-resistant bacterial strains since the 1960s boosted the development of carbohydrate-based vaccines and led to the approval of CPS-based vaccines against Neisseria meningitidis, Haemophilus influenzae type b (Hib), and Salmonella typhi. Meanwhile, it was observed that CPS generally do not elicit protective antibody responses in children below the age of 2 years who are at the greatest risk of infection. As a consequence, studies refocused on the conjugation of oligosaccharides to proteins in order to increase vaccine immunogenicity which led to the introduction of the first glycoconjugate vaccine against Hib in 1987. Due to the success of the first glycoconjugate vaccines, higher valent formulations were developed against numerous bacterial infections to achieve broad serotype coverage. Current research also focuses on the development of carbohydrate-based vaccines against other pathogens such as viruses, fungi, protozoan parasites, or helminths.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Colley, D. G., Bustinduy, A. L., Secor, W. E., & King, C. H. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61949-2 · Cited by 2,444
Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus
Tillett, W. S., & Francis, T. (1930) · Journal of Experimental Medicine · doi:10.1084/jem.52.4.561 · Cited by 1,482
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Immunological mechanisms of vaccination
Pulendran, B., & Ahmed, R. (2011) · Nature Immunology · doi:10.1038/ni.2039 · Cited by 1,089
Global Trends in Typhoid and Paratyphoid Fever
Crump, J. A., & Mintz, E. D. (2010) · Clinical Infectious Diseases · doi:10.1086/649541 · Cited by 888
T Cell-Independent Antigens Type 2
Mond, J. J. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.655 · Cited by 824
Carbohydrate vaccines: developing sweet solutions to sticky situations?
Astronomo, R. D., & Burton, D. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3012 · Cited by 629
Research works printed but not linked: 2
- Landsteiner K (1921) Über heterogenetisches antigen und hapten. XV. Mitteilung über antigene. Biochem Z 119:294–306
- Cummings R, Turco S (2009) Parasitic Infections. In: Varki A et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor (NY), New York
Cited by
Understanding modern-day vaccines: what you need to know
Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., & Shapiro, M. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1407035 · Cited by 354
“due to the immaturity of their immune system [51].”
BackgroundManganese salts function as potent adjuvants
Zhang, R., Wang, C., Guan, Y., Wei, X., Sha, M., Yi, M., Jing, M., Lv, M., Guo, W., Xu, J., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00669-w · Cited by 313
Toward Automated Enzymatic Synthesis of Oligosaccharides
Wen, L., Edmunds, G., Gibbons, C., Zhang, J., Gadi, M. R., Zhu, H., Fang, J., Liu, X., Kong, Y., & Wang, P. G. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00066 · Cited by 214
Global mapping of glycosylation pathways in human-derived cells
Huang, Y.-F., Aoki, K., Akase, S., Ishihara, M., Liu, Y.-S., Yang, G., Kizuka, Y., Mizumoto, S., Tiemeyer, M., Gao, X.-D., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.023 · Cited by 113
“Therefore, determining the structures of complex glycans can lead to both the identification of glycan biomarkers and the development of vaccines and therapeutics in biomedical and biotechnological contexts (Hutter and Lepenies, 2015; Mereiter et al., 2019).”
BackgroundValverde, P., Ardá, A., Reichardt, N., Jiménez‐Barbero, J., & Gimeno, A. (2019) · MedChemComm · doi:10.1039/c9md00292h · Cited by 96
Metadata
- Authors
- Hütter, J., & Lepenies, B.
- Affiliations
- Max Planck Society (DE)
- Max Planck Institute of Colloids and Interfaces (DE)
- Corresponding author
- Hütter, Julia
- Lepenies, Bernd
- Venue
- Methods in molecular biology
- Publisher
- Springer New York
- Published
- 2015
- Volume
- 1331
- Pages
- 1-10
- ISSN
- 1064-3745 (ISSN-L)
- 1940-6029
- OpenAlex
- W900652074
- Cited by
- 55
- References
- 69
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 9 · 2018: 8 · 2017: 5 · 2016: 4
- FWCI
- 12.92
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Methods in molecular biology (publishedVersion)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- carbohydrate-based vaccines, capsular polysaccharide, glycoconjugate vaccines, Streptococcus pneumoniae, Haemophilus influenzae type b, Neisseria meningitidis, Salmonella typhi, polysaccharide vaccine, vaccine immunogenicity, antibiotic resistance, serotype coverage
- MeSH terms
- Antibodies, Bacterial, Bacterial Vaccines, Carbohydrates, Glycoconjugates, Humans, Pneumococcal Infections, Streptococcus pneumoniae, Vaccination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carbohydrate-Based Vaccines: An Overview. https://app.cochat.ai/papers/10.1007/978-1-4939-2874-3_1
- The paper
- Hütter, J., & Lepenies, B. (2015). Carbohydrate-Based Vaccines: An Overview. Methods in molecular biology. https://doi.org/10.1007/978-1-4939-2874-3_1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.